Pregled bibliografske jedinice broj: 830124
Macrolones Are a Novel Class of Macrolide Antibiotics Active against Key Resistant Respiratory Pathogens In Vitro and In Vivo
Macrolones Are a Novel Class of Macrolide Antibiotics Active against Key Resistant Respiratory Pathogens In Vitro and In Vivo // Antimicrobial agents and chemotherapy, 60 (2016), 9; 5337-5348 doi:10.1128/AAC.00524-16 (međunarodna recenzija, članak, znanstveni)
CROSBI ID: 830124 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Macrolones Are a Novel Class of Macrolide Antibiotics Active against Key Resistant Respiratory Pathogens In Vitro and In Vivo
Autori
Čipčić Paljetak, Hana ; Verbanac, Donatella ; Padovan, Jasna ; Dominis-Kramarić, Miroslava ; Kelnerić, Željko ; Banjanac, Mihailo ; Ergović, Gabrijela ; Simon, Nerrisa ; Broskey, John ; Holmes, David ; Eraković Haber, Vesna
Izvornik
Antimicrobial agents and chemotherapy (0066-4804) 60
(2016), 9;
5337-5348
Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, znanstveni
Ključne riječi
macrolides ; quinolones ; antibiotic resistance ; pneumonia ; animal models ; antibacterial activity
Sažetak
As we face an alarming increase in bacterial resistance to current antibacterial chemotherapeutics, expanding the available therapeutic arsenal in the fight against resistant bacterial pathogens causing respiratory tract infections is of high importance. The antibacterial potency of macrolones, a novel class of macrolide antibiotics, against key respiratory pathogens was evaluated in vitro and in vivo. MIC values against Streptococcus pneumoniae, Streptococcus pyogenes, Staphylococcus aureus, and Haemophilus influenzae strains sensitive to macrolide antibiotics and with defined macrolide resistance mechanisms were determined. The propensity of macrolones to induce the expression of inducible erm genes was tested by the triple-disk method and incubation in the presence of subinhibitory concentrations of compounds. In vivo efficacy was assessed in a murine model of S. pneumoniae- induced pneumonia, and pharmacokinetic (PK) profiles in mice were determined. The in vitro antibacterial profiles of macrolones were superior to those of marketed macrolide antibiotics, including the ketolide telithromycin, and the compounds did not induce the expression of inducible erm genes. They acted as typical protein synthesis inhibitors in an Escherichia coli transcription/translation assay. Macrolones were characterized by low to moderate systemic clearance, a large volume of distribution, a long half-life, and low oral bioavailability. They were highly efficacious in a murine model of pneumonia after intraperitoneal application even against an S. pneumoniae strain with constitutive resistance to macrolide-lincosamide-streptogramin B antibiotics. Macrolones are the class of macrolide antibiotics with an outstanding antibacterial profile and reasonable PK parameters resulting in good in vivo efficacy.
Izvorni jezik
Engleski
Znanstvena područja
Farmacija
Napomena
Riječ je o izvornom znastvenom članku
POVEZANOST RADA
Projekti:
HRZZ 5457
Ustanove:
Medicinski fakultet, Zagreb
Profili:
Miroslava Dominis-Kramarić
(autor)
Gabrijela Ergović
(autor)
Hana Čipčić Paljetak
(autor)
Donatella Verbanac
(autor)
Željko Kelnerić
(autor)
Mihailo Banjanac
(autor)
Vesna Eraković Haber
(autor)
Jasna Padovan
(autor)
Citiraj ovu publikaciju:
Časopis indeksira:
- Current Contents Connect (CCC)
- Web of Science Core Collection (WoSCC)
- Science Citation Index Expanded (SCI-EXP)
- SCI-EXP, SSCI i/ili A&HCI
- Scopus
- MEDLINE